GlassScriptPhysician profile
Star V Fowler
NPI 1588891782
$594.64
in general payments reported to CMS, 2019-2025
13 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.86 · 2021: $20.34 · 2022: $33.60 · 2023: $98.11 · 2024: $121 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $125.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $113.89 | 2024-2025 | |
| Amgen INC. | $70.26 | 2024-2025 | Evenity, Prolia |
| Celgene Corporation | $54.56 | 2022-2024 | Reblozyl |
| Glaxosmithkline, LLC. | $44.82 | 2019 | |
| Abbvie INC. | $33.63 | 2023 | |
| Novo Nordisk INC | $31.41 | 2025 | |
| Alkermes, INC. | $22.85 | 2024 | Vivitrol |
| Sanofi Pasteur INC. | $22.04 | 2019 | |
| Merck Sharp & Dohme LLC | $20.34 | 2021 | |
| Edwards Lifesciences Corporation | $20.00 | 2022 | |
| Dexcom, INC. | $18.19 | 2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $17.00 | 2025 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Star Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.